Vanta Bioscience (BOM:540729) ROCE % : -6.52% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vanta Bioscience's annualized ROCE % for the quarter that ended in Sep. 2024 was -6.52%.

Vanta Bioscience ROCE % Historical Data

The historical data trend for Vanta Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience ROCE % Chart

Vanta Bioscience Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

8.76

5.67

4.66

-6.95

-4.79

Vanta Bioscience Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial											-5.73	-8.73	1.65	-11.35	-6.52

Vanta Bioscience ROCE % Calculation

Vanta Bioscience's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-31.032	/	( ( (847.091 - 177.47)	+	(853.966 - 228.767) )	/ 2 )
	=	-31.032	/	( (669.621	+	625.199)	/ 2 )
	=	-31.032	/	647.41
	=	-4.79 %

Vanta Bioscience's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	-40.63	/	( ( (853.966 - 228.767)	+	(856.452 - 234.843) )	/ 2 )
	=	-40.63	/	( ( 625.199	+	621.609 )	/ 2 )
	=	-40.63	/	623.404
	=	-6.52 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Vanta Bioscience (BOM:540729) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vanta Bioscience ROCE % Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vanta Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003

Website

https://www.vantabio.com

Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines